Literature DB >> 31707229

Kinetic study of Aβ(1-42) amyloidosis in the presence of ganglioside-containing vesicles.

Yanping Dai1, Mingxi Zhang2, Xiulei Shi3, Kang Wang1, Guanbin Gao3, Lei Shen1, Taolei Sun4.   

Abstract

Alzheimer's disease (AD) is characterized by the amyloid-beta peptide (Aβ) misfolding to form aberrant amyloid aggregates in the brain. Although recent evidence implicates that amyloid deposition in vivo is highly related to biomembranes, how the characteristic lipid components of neuronal membranes mediate this process remains to be fully elucidated. Herein, we established vesicle models to mimic exosomes and investigated their influence on the kinetics of Aβ(1-42) amyloidosis. By using ternary vesicles composed of three brain lipids monosialoganglioside GM1, cholesterol and sphingomyelin, we found that GM1 could regulate peptide fibrillation by facilitating the conformational transition of Aβ(1-42), and further quantitatively analyzed the influence of GM1-containing vesicles on the kinetics of Aβ(1-42) fibrillation. In addition, GM1-containing vesicles induced the formation of Aβ(1-42) fibrils at low concentrations, and these fibrils were toxic to PC12 cells. By analyzing the role of GM1 in this ternary mixture of membranes at the molecular level, we confirmed that GM1 clusters are presented as attachment sites for peptides, thus promoting the fibrillation of Aβ(1-42).
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Aβ(1-42); Fibrillation; Ganglioside; Vesicles

Mesh:

Substances:

Year:  2019        PMID: 31707229     DOI: 10.1016/j.colsurfb.2019.110615

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  8 in total

Review 1.  Implications of Sphingolipid Metabolites in Kidney Diseases.

Authors:  Shamroop Kumar Mallela; Sandra Merscher; Alessia Fornoni
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 2.  Sphingolipid Players in Multiple Sclerosis: Their Influence on the Initiation and Course of the Disease.

Authors:  Maria Podbielska; Toshio Ariga; Anna Pokryszko-Dragan
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

Review 3.  Exploring Sphingolipid Implications in Neurodegeneration.

Authors:  Alice V Alessenko; Elisabetta Albi
Journal:  Front Neurol       Date:  2020-05-21       Impact factor: 4.003

Review 4.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 5.  Structure and function of glycosphingolipids on small extracellular vesicles.

Authors:  Xin He; Feng Guan; Lei Lei
Journal:  Glycoconj J       Date:  2022-02-24       Impact factor: 3.009

Review 6.  Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.

Authors:  Vladimir Rudajev; Jiri Novotny
Journal:  Front Mol Neurosci       Date:  2022-08-25       Impact factor: 6.261

7.  Early stage β-amyloid-membrane interactions modulate lipid dynamics and influence structural interfaces and fibrillation.

Authors:  June M Kenyaga; Qinghui Cheng; Wei Qiang
Journal:  J Biol Chem       Date:  2022-09-14       Impact factor: 5.486

Review 8.  A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Authors:  Brianna M Quinville; Natalie M Deschenes; Alex E Ryckman; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.